Palisade Bio (PALI) Current Leases (2020 - 2025)
Palisade Bio's (PALI) quarterly Current Leases came in at $24000.0 in Q2 2025, down 81.54% year-on-year from $130000.0 in Q2 2024, and down 58.62% on a QoQ basis from $58000.0 in Q1 2025.
Palisade Bio (PALI) Current Leases (2020 - 2025) Analysis & Trends
Palisade Bio (PALI) has 6 years of Current Leases data on file, last reported at $24000.0 in Q2 2025.
- On a quarterly basis, Current Leases fell 81.54% year-over-year to $24000.0 in Q2 2025; TTM through Jun 2025 was $24000.0, a 81.54% decrease from a year earlier, with the FY2024 full-year figure at $90000.0, down 25.62% from the prior year.
- Current Leases for Q2 2025 stood at $24000.0, down from $58000.0 in the prior quarter.
- Over the last five years, Current Leases for PALI reached as high as $184000.0 in Q2 2021 and fell as low as $24000.0 in Q2 2025.
- Historically, Current Leases has averaged $107764.7 across 5 years, with a median of $112000.0 in 2021.
- Across the five-year window, Current Leases soared 67.69% in 2023 and tumbled 81.54% in 2025, its largest moves.
- Year by year, Current Leases stood at $112000.0 in 2021, then fell by 6.25% to $105000.0 in 2022, then gained by 15.24% to $121000.0 in 2023, then declined by 25.62% to $90000.0 in 2024, then plunged by 73.33% to $24000.0 in 2025.
- Per Business Quant data, the three most recent Current Leases figures were $24000.0 in Q2 2025, $58000.0 in Q1 2025, and $90000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Dec 31, 2020 | 168,000.00 |